Physician profile
Kurt Lundberg
NPI 1689930927
$11,228.87
in general payments reported to CMS, 2019-2025
19 companies · $774 in 2025
The $774 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,405 · 2020: $1,209 · 2021: $1,708 · 2022: $2,322 · 2023: $1,610 · 2024: $2,200 · 2025: $774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,674 · Travel and Lodging: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,673.81 |
| Travel and Lodging | $910.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,309.41 | 2019-2025 | Proclaim, Prodigy, Infinity |
| Medtronic, INC. | $1,396.17 | 2021-2025 | Kyphon Express II Kyphopak Tray, Interstim, Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $691.83 | 2020-2025 | Xtampza |
| Nevro Corp. | $634.01 | 2019-2022 | |
| Nalu Medical, INC. | $365.60 | 2023-2024 | Nalu Neurostimulation System |
| Abbvie INC. | $243.24 | 2021-2025 | |
| Medtronic USA, INC. | $236.25 | 2019-2020 | |
| Mml US, INC. | $196.82 | 2024 | Reactiv8 |
| Biodelivery Sciences International, INC. | $161.65 | 2019-2021 | |
| Corelink, LLC | $147.90 | 2023 | |
| Spr Therapeutics, INC | $145.95 | 2024 | Sprint Pns System |
| Boston Scientific Corporation | $144.18 | 2022 | |
| Relievant Medsystems, INC. | $136.20 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $124.94 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $63.95 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.47 | 2021 | |
| Pacira Therapeutics, INC. | $37.69 | 2021 | |
| Biotronik Nro, INC. | $15.61 | 2025 | Prospera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Lundberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.